Jim Wassil Vaxcyte, Inc. (PCVX) insider trading activity

PCVX Quotes by TradingView

Jim Wassil is CHIEF OPERATING OFFICER of Vaxcyte, Inc.. Currently has a direct ownership of 151,916 shares of PCVX, which is worth approximately $5.74 Million. The most recent transaction as insider was on Mar 02, 2023, when has been sold 1,189 shares (Common Stock) at a price of $41.49 per share, resulting in proceeds of $49,331. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 152K
26.15% 3M change
30.41% 12M change
Total Value Held $5.74 Million

Jim Wassil Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 02 2023
SELL
Payment of exercise price or tax liability
$49,331 $41.49 p/Share
1,189 Reduced 0.7%
169,026 Common Stock
Mar 01 2023
BUY
Grant, award, or other acquisition
-
22,500 Added 11.68%
170,215 Common Stock
Dec 23 2022
BUY
Exercise of conversion of derivative security
$254,997 $2.42 p/Share
105,371 Added 41.63%
147,715 Common Stock
Oct 17 2022
SELL
Open market or private sale
$71,708 $25.61 p/Share
2,800 Reduced 6.2%
42,344 Common Stock
Oct 17 2022
BUY
Exercise of conversion of derivative security
$6,776 $2.42 p/Share
2,800 Added 5.84%
45,144 Common Stock
Sep 19 2022
SELL
Open market or private sale
$73,724 $26.33 p/Share
2,800 Reduced 6.2%
42,344 Common Stock
Sep 19 2022
BUY
Exercise of conversion of derivative security
$6,776 $2.42 p/Share
2,800 Added 5.84%
45,144 Common Stock
Sep 02 2022
SELL
Payment of exercise price or tax liability
$57,034 $26.38 p/Share
2,162 Reduced 4.86%
42,344 Common Stock
Aug 17 2022
SELL
Open market or private sale
$70,420 $25.15 p/Share
2,800 Reduced 5.92%
44,506 Common Stock
Aug 17 2022
BUY
Exercise of conversion of derivative security
$6,776 $2.42 p/Share
2,800 Added 5.59%
47,306 Common Stock
Jul 01 2022
SELL
Open market or private sale
$61,600 $22.0 p/Share
2,800 Reduced 5.92%
44,506 Common Stock
Jul 01 2022
BUY
Exercise of conversion of derivative security
$6,776 $2.42 p/Share
2,800 Added 5.59%
47,306 Common Stock
Apr 18 2022
SELL
Open market or private sale
$67,144 $23.98 p/Share
2,800 Reduced 6.12%
42,944 Common Stock
Apr 18 2022
BUY
Exercise of conversion of derivative security
$6,776 $2.42 p/Share
2,800 Added 5.77%
45,744 Common Stock
Mar 02 2022
BUY
Grant, award, or other acquisition
-
25,000 Added 36.8%
42,944 Common Stock
Feb 24 2022
SELL
Open market or private sale
$220,000 $22.0 p/Share
10,000 Reduced 35.79%
17,944 Common Stock
Feb 24 2022
BUY
Exercise of conversion of derivative security
$24,200 $2.42 p/Share
10,000 Added 26.35%
27,944 Common Stock
Feb 22 2021
SELL
Open market or private sale
$80,130 $26.71 p/Share
3,000 Reduced 15.48%
16,381 Common Stock
Feb 22 2021
BUY
Exercise of conversion of derivative security
$7,260 $2.42 p/Share
3,000 Added 13.4%
19,381 Common Stock
Jan 20 2021
SELL
Open market or private sale
$76,500 $25.5 p/Share
3,000 Reduced 15.48%
16,381 Common Stock
Jan 20 2021
BUY
Exercise of conversion of derivative security
$7,260 $2.42 p/Share
3,000 Added 13.4%
19,381 Common Stock

Also insider at

ICVX
Icosavax, Inc. Healthcare
JW

Jim Wassil

CHIEF OPERATING OFFICER
San Carlos, CA

Track Institutional and Insider Activities on PCVX

Follow Vaxcyte, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCVX shares.

Notify only if

Insider Trading

Get notified when an Vaxcyte, Inc. insider buys or sells PCVX shares.

Notify only if

News

Receive news related to Vaxcyte, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PCVX